New agents for treatment of advanced transitional cell carcinoma.

@article{Perabo2007NewAF,
  title={New agents for treatment of advanced transitional cell carcinoma.},
  author={F. Perabo and S. M{\"u}ller},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2007},
  volume={18 5},
  pages={
          835-43
        }
}
  • F. Perabo, S. Müller
  • Published 2007
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
The prognosis for any patient with progressive or recurrent invasive transitional cell carcinoma remains poor. In this context, the focus of clinical research in these invasive cancers concentrates on identifying systemic treatment options and new agents in order to improve survival of patients. Cisplatin-based chemotherapy is standard treatment of patients with metastatic urothelial cancer; however, despite regimens as the cisplatin-gemcitabine combination, the overall response rates vary… Expand
Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report
Upregulation of Key Molecules for Targeted Imaging and Therapy
Lobaplatin Inhibits the Proliferation of Hepatollular Carcinoma Through P53 Apoptosis Axis
...
1
2
3
...

References

SHOWING 1-10 OF 90 REFERENCES
...
1
2
3
4
5
...